lebrikizumab   Click here for help

GtoPdb Ligand ID: 7684

Synonyms: Ebglyss® | lebrikizumab-lbkz | MILR1444A | RG3637 | TNX-650
Approved drug Immunopharmacology Ligand
lebrikizumab is an approved drug (EMA (2023), FDA (2024))
Compound class: Antibody
Comment: Lebrikizumab is a an anti-IL-13 monoclonal antibody.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record.
Immunopharmacology Disease
Disease X-Refs Comment References
Idiopathic pulmonary fibrosis Disease Ontology: DOID:0050156
Orphanet: ORPHA2032
 Repurposed clinical candidate for IPF (Phase 2).
Asthma Disease Ontology: DOID:2841
OMIM: 600807
 Repurposed clinical candidate for asthma (Phase 3).